Stocks and Investing Stocks and Investing
Fri, July 28, 2023
Thu, July 27, 2023

Oren Livnat Maintained (VRCA) at Strong Buy with Increased Target to $12 on, Jul 27th, 2023


Published on 2024-10-28 05:12:01 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $11 to $12 on, Jul 27th, 2023.

Oren has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Oren


  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $14 on, Tuesday, July 25th, 2023
  • Serge Belanger of "Needham" Upgraded from Hold to Strong Buy and Held Target at $10 on, Tuesday, July 25th, 2023